|
Jones Pharma is a specialty pharmaceuticals manufacturer and marketer based in St. Louis, MO. The company was founded on March 16, 1981 by Dennis M. Jones and Judith Pearce Jones under the name Jones Medical Industries. The company completed its initial public offering in 1986, trading under the ticker symbol JMED on the NASDAQ. The primary therapeutic compounds marketed by the company include Thrombin-JMI〔(【引用サイトリンク】title=Thrombin-Jmi )〕 and Levoxyl〔(【引用サイトリンク】title=Levoxyl® (levothyroxine sodium tablets, USP) | Safety Info )〕 On May 30, 2000 the company became a wholly owned subsidiary of King Pharmaceuticals (NYSE:KG), based in Bristol, TN. The market value of the company on its closing trade was $3.6 billion.〔(prnewswire.com )〕〔(【引用サイトリンク】title=Dennis Jones - St. Louis Business Journal )〕 Parent company King Pharmaceuticals was acquired by Pfizer in 2010. ==References== *Gannon, Niall (2010). "Investing Strategies for the High Net Worth Investor", p. 233-245. McGraw Hill, New York. ISBN 978-0-07-162820-4 *Socha, Rudy & Darrow, Carolyn (2003). "Above and Beyond: Former Marines Conquer the Civilian World", p. 110. Turner Publishing, Paducha. ISBN 1-56311-949-8 *Wall Street Journal Article Ranks Jones Pharma 23rd in Five-Year Return Among Top 1000 U.S. Companies (Wall Street Journal Article Ranks Jones Pharma 23rd in Five-Year Return Among Top 1000 U.S. Companies ) *King Pharmaceuticals merging with Jones Pharma in $3.4 Billion Deal (thepharmaletter.com ) *St. Louis Business Journal: He’s a multimillionaire who never went to college, yet within 20 years built Jones Pharma into a business that was acquired for $3.4 billion () *Read more: Dennis Jones - St. Louis Business Journal 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Jones Pharma」の詳細全文を読む スポンサード リンク
|